Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Square Pharmaceuticals Ltd (SQPH)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
207.70 -4.40    -2.07%
25/04 - Closed. Currency in BDT ( Disclaimer )
  • Volume: 137,820
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 205.80 - 212.10
Type:  Equity
Market:  Bangladesh
ISIN:  BD0473SQPH00 
S/N:  SQURPHARMA
Square Pharma 207.70 -4.40 -2.07%

SQPH Balance Sheet

 
Assess the latest Square Pharmaceuticals Ltd balance sheet. Review the company's financial position, assess their current assets, liabilities and shareholder equity across the most recent periods (either quarterly or annually).

Even more advanced SQPH Annual Report data, financial summaries and charts are available for Square Pharmaceuticals Ltd investors with their own InvestingPro account.
AnnualQuarterly
InvestingPro Advanced Balance Sheet
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Total Current Assets 78175.62 74802.67 70487.12 67146.21
Cash and Short Term Investments 57663.2 56752.06 50094.32 50490.88
Cash - - - -
Cash & Equivalents 57663.2 56752.06 50094.32 50490.88
Short Term Investments - - - -
Total Receivables, Net 4938.78 4923.47 6122.29 3792.67
Accounts Receivables - Trade, Net 2839.59 2622.34 - 2588.4
Total Inventory 12260.1 11320.19 12227.2 11264.56
Prepaid Expenses 52.57 68.41 - 18.63
Other Current Assets, Total 3260.96 1738.55 1961.68 1579.47
Total Assets 135934.01 128168.22 121816.31 117379.81
Property/Plant/Equipment, Total - Net 25758.95 25870.83 - 27815.02
Property/Plant/Equipment, Total - Gross 50477.51 50016.39 - 52928.76
Accumulated Depreciation, Total -24718.56 -24145.56 -23428.73 -25113.74
Goodwill, Net - - - -
Intangibles, Net - - - -
Long Term Investments 31999.44 27494.72 25270.37 22418.58
Note Receivable - Long Term 2099.19 2301.13 2701.57 1204.27
Other Long Term Assets, Total - - - -
Other Assets, Total 10582.28 8135.26 8066.59 9051.36
Total Current Liabilities 16706.41 4713.69 4229.15 5430.07
Accounts Payable 3383.44 1065.7 1001.76 1100.03
Payable/Accrued - - - -
Accrued Expenses 1550.1 1622.74 1326.58 1595.91
Notes Payable/Short Term Debt - - - -
Current Port. of LT Debt/Capital Leases 566.22 576.33 618.61 440.95
Other Current liabilities, Total 11206.65 1448.93 1282.19 2293.19
Total Liabilities 18860.17 6909.28 6619.66 8051.07
Total Long Term Debt 1049.34 1208.57 1368.36 1471.95
Long Term Debt 1049.34 1208.57 1368.36 1471.95
Capital Lease Obligations - - - -
Deferred Income Tax 1104.42 987.02 1022.15 1149.05
Minority Interest 1.31 1.05 - 0.252
Other Liabilities, Total -1616.87 -1785.94 -1987.68 -1913.15
Total Equity 117073.84 121258.94 115196.65 109328.74
Redeemable Preferred Stock, Total - - - -
Preferred Stock - Non Redeemable, Net - - - -
Common Stock, Total 8864.51 8864.51 - 8864.51
Additional Paid-In Capital 2035.46 2035.46 2035.46 2035.46
Retained Earnings (Accumulated Deficit) 105515.99 109578.74 103578.36 97758.41
Treasury Stock - Common - - - -
ESOP Debt Guarantee - - - -
Unrealized Gain (Loss) - - - -
Other Equity, Total 657.88 780.23 718.31 670.35
Total Liabilities & Shareholders' Equity 135934.01 128168.22 121816.31 117379.81
Total Common Shares Outstanding 886.45 886.45 886.45 886.45
Total Preferred Shares Outstanding - - - -
* In Millions of BDT (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the balance sheet, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SQPH Price Commentary

Write your thoughts about Square Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nasir Kabul
Nasir Kabul Nov 09, 2021 16:48
Saved. See Saved Items.
This comment has already been saved in your Saved Items
low risk company
Mizanur Rahman Kiron
Mizanur Rahman Kiron Oct 25, 2021 5:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
silent killer....
KRISHNA CHARAN DEBNATH
KRISHNA CHARAN DEBNATH Sep 19, 2021 18:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
It's strong and steady.
Rahat Hossain
Rahat Hossain Mar 06, 2021 15:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
No chance of loss ever
Sohrab Hossain
Sohrab Hossain Sep 25, 2020 7:27
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What will the future of this share?
Saiful Islam
Saiful Islam Aug 04, 2020 11:04
Saved. See Saved Items.
This comment has already been saved in your Saved Items
its time now to buy
Rayhan Peyash
Rayhan Peyash Jun 27, 2019 20:58
Saved. See Saved Items.
This comment has already been saved in your Saved Items
how
Nahid Morshed
Nahid Morshed Dec 12, 2018 6:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
best fundamental company in Bangladesh stock market
BAy Zid
BAy Zid Dec 12, 2018 6:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
really
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email